reference/7885001

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7885001

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial
endingPage	853
issn	1538-7836
issueIdentifier	5
pageRange	848-853
publicationName	Journal of thrombosis and haemostasis : JTH
startingPage	848
bibliographicCitation	FINAZZI G, MARCHIOLI R, BRANCACCIO V, SCHINCO P, WISLOFF F, MUSIAL J, BAUDO F, BERRETTINI M, Testa S, D'ANGELO A, TOGNONI G, BARBUI T. A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). Journal of Thrombosis and Haemostasis. 2005 May;3(5):848–53. doi: 10.1111/j.1538-7836.2005.01340.x.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a946d86d8bb9eda83bbcc7a14ddf74ef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8372843465ff4c769aea1366ae0c8776 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af9ade4de984103947806d628bdad475 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3ed4af6aa617a29e5a4b8d0e8ccebb0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2faefe416ebb45e6228318bba1e7940 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8eacc92bcceffc904b22a0d4aa8f5e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00bd62e7c7d94666e5dd6b110891e935 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd4005dcc373f7e8fdc948ecd70d6f8f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e97c21f6f564512ac62373d29f82a8a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a15f57b5fb7bedba74791038f20c5d79 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39653dfa9cc3309097f0fda8fccb9c0c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78628434054257c0e56221d922d356f7
date	200505
identifier	https://pubmed.ncbi.nlm.nih.gov/15869575 https://doi.org/10.1111/j.1538-7836.2005.01340.x
isPartOf	https://portal.issn.org/resource/ISSN/1538-7836 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30450
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)
discusses	http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0008434 http://id.nlm.nih.gov/mesh/M0026053 http://id.nlm.nih.gov/mesh/M0022871 http://id.nlm.nih.gov/mesh/M0001380
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D013927Q000473 http://id.nlm.nih.gov/mesh/D013927Q000517 http://id.nlm.nih.gov/mesh/D005343Q000494 http://id.nlm.nih.gov/mesh/D016736Q000188 http://id.nlm.nih.gov/mesh/D014859Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D012306 http://id.nlm.nih.gov/mesh/D000465 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000925Q000627 http://id.nlm.nih.gov/mesh/D017153Q000737 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D001241Q000627 http://id.nlm.nih.gov/mesh/D016017 http://id.nlm.nih.gov/mesh/D019934 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D012008 http://id.nlm.nih.gov/mesh/D013223 http://id.nlm.nih.gov/mesh/D002986 http://id.nlm.nih.gov/mesh/D013923Q000188 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9410 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9918 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54678486

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128926582 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695

Total number of triples: 66.